Qu Biologics is pleased to announce the appointment of Karn Manhas to Qu’s Board of Directors
24. August 2020 06:00 ET
|
Qu Biologics, Inc.
VANCOUVER, British Columbia, Aug. 24, 2020 (GLOBE NEWSWIRE) -- Qu Biologics Inc., a biopharmaceutical company developing Site Specific Immunomodulators (SSIs), a novel platform of immunotherapies...